No CrossRef data available.
Article contents
Auranofin attenuates Schistosoma mansoni egg-induced liver granuloma and fibrosis in mice
Published online by Cambridge University Press: 06 December 2023
Abstract
Schistosomiasis is a serious tropical disease. Despite extensive research into the etiology of liver fibrosis, effective therapeutic options remain limited. This study aims to assess the effectiveness of auranofin in treating hepatic granuloma and fibrogenesis produced by Schistosoma (S.) mansoni eggs. Auranofin is a gold complex that contains thioglucose tetraacetate and triethylphosphine. Eighty BALB/c male mice were divided into four groups (n=20/group): negative control (GI), positive control (GII), and early (GIII) and late (GIV) treatment groups with oral auranofin according to beginning of treatment 4th week and 6th week post-infection. Mice were infected subcutaneously in a dose of 60±10 cercariae/mouse. Worm counts, egg loads, and oogram patterns were determined. Biochemical, histological, and immunostaining of interleukin-1β (IL-1β), Sirtuin 3 (SIRT3), and smooth muscle actin (SMA) were assessed. GIII showed a significant decrease in the total S. mansoni worm burden and ova/gram in liver tissue (with reduction percent of 63.07% and 78.26%, respectively). Schistosomal oogram patterns, immature and mature ova, also showed a significant decrease. The reduction in granuloma number and size was 40.63% and 48.66%, respectively, in GIII, whereas in GIV, the reduction percent was 76.63% and 67.08%. In addition, the degree of fibrosis was significantly diminished in both treated groups. GIV showed significant reduction in IL-1β and SMA expression and increase in SIRT3 expression. These findings reveal how auranofin suppresses the development of liver fibrosis. Therefore, it is crucial to take another look at auranofin as a prospective medication for the treatment of S. mansoni egg-induced hepatic granuloma and consequent fibrosis.
- Type
- Research Paper
- Information
- Copyright
- © The Author(s), 2023. Published by Cambridge University Press
References
Al Mamun, A, Akter, A, Hossain, S, Sarker, T, Safa, SA, Mustafa, QG, Muhammad, SA, and Munir, F (2020) Role of NLRP3 inflammasome in liver disease. Journal of Digestive Diseases 21, 430–436. doi: 10.1111/1751-2980.12918CrossRefGoogle ScholarPubMed
Alegre, F, Pelegrin, P, and Feldstein, AE (2017) Inflammasomes in liver fibrosis. Seminars in Liver Disease 37, 119–127. doi: 10.1055/s-0037-1601350CrossRefGoogle ScholarPubMed
Amaral, KB, Silva, TP, Dias, FF, Malta, KK, Rosa, FM, Costa-Neto, SF, Gentile, R, and Melo, RC (2017) Histological assessment of granulomas in natural and experimental Schistosoma mansoni infections using whole slide imaging. PLoS One 12, e0184696.CrossRefGoogle ScholarPubMed
Andrade, RM, Chaparro, JD, Capparelli, E, and Reed, SL (2014) Auranofin is highly efficacious against Toxoplasma gondii in vitro and in an in vivo experimental model of acute toxoplasmosis. PLOS Neglected Tropical Diseases 8, e2973. doi: 10.1371/journal.pntd.0002973CrossRefGoogle Scholar
Angelucci, F, Sayed, AA, Williams, DL, Boumis, G, Brunori, M, Dimastrogiovanni, D, Miele, AE, Pauly, F, and Bellelli, A (2009) Inhibition of Schistosoma mansoni thioredoxin-glutathione reductase by auranofin: structural and kinetic aspects. Journal of Biological Chemistry 284, 28977–28985. doi: 10.1074/jbc.M109.020701CrossRefGoogle ScholarPubMed
Bancroft, J and Gamble, M (2008) Theory and practice of histology techniques. London, Churchill Livingstone Elsevier, 83–134.Google Scholar
Bergmeyer, H, Horder, M, and Rej, R (1986) Approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 2. IFCC method for aspartate aminotransferase (L-aspartate: 2-oxoglutarate aminotransferase, EC 2.6. 1.1). Journal of Clinical Chemistry and Clinical Biochemistry 24, 497–508.Google ScholarPubMed
Cao, Z, Wang, Y, Long, Z, and He, G (2019) Interaction between autophagy and the NLRP3 inflammasome. Acta Biochimica et Biophysica Sinica (Shanghai) 51, 1087–1095. doi: 10.1093/abbs/gmz098CrossRefGoogle ScholarPubMed
Cheever, AW (1969) Quantitative comparison of the intensity of Schistosoma mansoni infections in man and experimental animals. Transactions of the Royal Society of Tropical Medicine and Hygiene 63, 781–795.CrossRefGoogle ScholarPubMed
Chen, S-Y, Chao, C-N, Huang, H-Y, and Fang, C-Y (2022) Auranofin induces urothelial carcinoma cell death via reactive oxygen species production and synergy with cisplatin. Oncology Letters 23, 61. doi: 10.3892/ol.2021.13179Google ScholarPubMed
Chen, TTW, Cheng, PC, Chang, KC, Cao, JP, Feng, JL, Chen, CC, Lam, HP, and Peng, SY (2019) Activation of the NLRP3 and AIM2 inflammasomes in a mouse model of Schistosoma mansoni infection. Journal of Helminthology 94, e72. doi: 10.1017/s0022149x19000622CrossRefGoogle Scholar
Chuah, C, Jones, MK, Burke, ML, McManus, DP, and Gobert, GN (2014) Cellular and chemokine-mediated regulation in schistosome-induced hepatic pathology. Trends in Parasitology 30, 141–150. doi: 10.1016/j.pt.2013.12.009CrossRefGoogle ScholarPubMed
Debnath, A, Ndao, M, and Reed, SL (2013) Reprofiled drug targets ancient protozoans. Gut Microbes 4, 66–71. doi: 10.4161/gmic.22596CrossRefGoogle ScholarPubMed
Ding, Y, Fu, X, Wang, Q, Liu, H, Wang, H, and Wu, D (2021) The complex interplay between autophagy and NLRP3 inflammasome in renal diseases. International Journal of Molecular Sciences 22(23), 12766. doi: 10.3390/ijms222312766CrossRefGoogle ScholarPubMed
El-Refai, S, Atia, A, and Mahmoud, S (2019) Effects of Callistemon citrinus aqueous extract on prepatent and patent infections with Schistosoma mansoni in experimentally infected mice. Journal of Helminthology, 93, 424–433.CrossRefGoogle ScholarPubMed
Franchi, L, Warner, N, Viani, K, and Nuñez, G (2009) Function of Nod-like receptors in microbial recognition and host defense. Immunological Reviews 227, 106–128. doi: 10.1111/j.1600-065X.2008.00734.xCrossRefGoogle ScholarPubMed
Gaul, S, Leszczynska, A, Alegre, F, Kaufmann, B, Johnson, CD, Adams, LA, Wree, A, Damm, G, Seehofer, D, and Calvente, CJ (2021) Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis. Journal of Hepatology 74, 156–167.CrossRefGoogle ScholarPubMed
Hao, YY, Cui, WW, Gao, HL, Wang, MY, Liu, Y, Li, CR, Hou, L, and Jia, ZH (2022) Jinlida granules ameliorate the high-fat-diet induced liver injury in mice by antagonising hepatocytes pyroptosis. Pharmaceutical Biology 60, 274–281. doi: 10.1080/13880209.2022.2029501CrossRefGoogle ScholarPubMed
He, Z, Chen, J, Zhu, X, An, S, Dong, X, Yu, J, Zhang, S, Wu, Y, Li, G, and Zhang, Y (2018) NLRP3 inflammasome activation mediates Zika virus–associated inflammation. The Journal of Infectious Diseases 217, 1942–1951.CrossRefGoogle ScholarPubMed
Hirschey, MD, Shimazu, T, Goetzman, E, Jing, E, Schwer, B, Lombard, DB, Grueter, CA, Harris, C, Biddinger, S, Ilkayeva, OR, Stevens, RD, Li, Y, Saha, AK, Ruderman, NB, Bain, JR, Newgard, CB, Farese, RV Jr, Alt, FW, Kahn, CR, and Verdin, E (2010) SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 464, 121–125. doi: 10.1038/nature08778CrossRefGoogle ScholarPubMed
Holanda, J, Pellegrino, J, and Gazzinelli, G (1974) Infection of mice with cercariae and schistosomula of Schistosoma mansoni by intravenous and subcutaneous routes. Revista do Instituto de Medicina Tropical de Sao Paulo 16, 132–134.Google ScholarPubMed
Hwangbo, H, Kim, MY, Ji, SY, Kim, SY, Lee, H, Kim, G-Y, Park, C, Keum, Y-S, Hong, SH, and Cheong, J (2020) Auranofin attenuates non-alcoholic fatty liver disease by suppressing lipid accumulation and NLRP3 inflammasome-mediated hepatic inflammation in vivo and in vitro. Antioxidants 9, 1040.CrossRefGoogle ScholarPubMed
Ilyas, G, Zhao, E, Liu, K, Lin, Y, Tesfa, L, Tanaka, KE, and Czaja, MJ (2016) Macrophage autophagy limits acute toxic liver injury in mice through down regulation of interleukin-1β. Journal of Hepatology 64, 118–127. doi: 10.1016/j.jhep.2015.08.019CrossRefGoogle ScholarPubMed
Inzaugarat, ME, Johnson, CD, Holtmann, TM, McGeough, MD, Trautwein, C, Papouchado, BG, Schwabe, R, Hoffman, HM, Wree, A, and Feldstein, AE (2019) NLR family pyrin domain-containing 3 inflammasome activation in hepatic stellate cells induces liver fibrosis in mice. Hepatology 69, 845–859. doi: 10.1002/hep.30252CrossRefGoogle ScholarPubMed
Isakov, E, Weisman-Shomer, P, and Benhar, M (2014) Suppression of the pro-inflammatory NLRP3/interleukin-1β pathway in macrophages by the thioredoxin reductase inhibitor auranofin. Biochimica Et Biophysica Acta (BBA)-General Subjects 1840, 3153–3161.CrossRefGoogle ScholarPubMed
Kaufmann, B, Kui, L, Reca, A, Leszczynska, A, Kim, AD, Booshehri, LM, Wree, A, Friess, H, Hartmann, D, and Broderick, L (2022) Cell-specific deletion of NLRP3 inflammasome identifies myeloid cells as key drivers of liver inflammation and fibrosis in murine steatohepatitis. Cellular and Molecular Gastroenterology and Hepatology, 14, 751–767.CrossRefGoogle ScholarPubMed
Khambu, B, Yan, S, Huda, N, Liu, G, and Yin, X-M (2018) Homeostatic role of autophagy in hepatocytes. In Seminars in Liver Disease. vol. 38. Thieme Medical Publishers, 308–319.Google Scholar
Kim, HY, Choi, YJ, Kim, SK, Kim, H, Jun, DW, Yoon, K, Kim, N, Hwang, J, Kim, Y-M, and Lim, SC (2021) Auranofin prevents liver fibrosis by system Xc-mediated inhibition of NLRP3 inflammasome. Communications Biology 4, 824.CrossRefGoogle ScholarPubMed
Kim, HY, Kim, KS, Kim, MJ, Kim, H-S, Lee, K-Y, and Kang, KW (2019) Auranofin inhibits RANKL-induced osteoclastogenesis by suppressing inhibitors of κB kinase and inflammasome-mediated interleukin-1β secretion. Oxidative Medicine and Cellular Longevity, 2019.CrossRefGoogle ScholarPubMed
Kuntz, AN, Davioud-Charvet, E, Sayed, AA, Califf, LL, Dessolin, J, Arnér, ES, and Williams, DL (2007) Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target. PLoS Medicine 4, e206. doi: 10.1371/journal.pmed.0040206CrossRefGoogle Scholar
Lee, D, Xu, IMJ, Chiu, DKC, Leibold, J, Tse, APW, Bao, MHR, Yuen, VWH, Chan, CYK, Lai, RKH, and Chin, DWC (2019) Induction of oxidative stress through inhibition of thioredoxin reductase 1 is an effective therapeutic approach for hepatocellular carcinoma. Hepatology 69, 1768–1786.CrossRefGoogle ScholarPubMed
Lee, H-M, Kim, J-J, Kim, HJ, Shong, M, Ku, BJ, and Jo, E-K (2013) Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes. Diabetes 62, 194–204.CrossRefGoogle ScholarPubMed
Lee, HY, Kim, J, Quan, W, Lee, JC, Kim, MS, Kim, SH, Bae, JW, Hur, KY, and Lee, MS (2016) Autophagy deficiency in myeloid cells increases susceptibility to obesity-induced diabetes and experimental colitis. Autophagy 12, 1390–1403. doi: 10.1080/15548627.2016.1184799CrossRefGoogle ScholarPubMed
Levine, B and Deretic, V (2007) Unveiling the roles of autophagy in innate and adaptive immunity. Nature Reviews Immunology 7, 767–777. doi: 10.1038/nri2161CrossRefGoogle ScholarPubMed
Liang, Y, Bruce, J, and Boyd, D (1987) Laboratory cultivation of schistosome vector snails and maintenance of schistosome life cycles. In Proceeding of the 1st Sino-American Symposium, vol. 1, 34–48.Google Scholar
Liu, P, Huang, G, Wei, T, Gao, J, Huang, C, Sun, M, Zhu, L, and Shen, W (2018) Sirtuin 3-induced macrophage autophagy in regulating NLRP3 inflammasome activation. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1864, 764–777.CrossRefGoogle ScholarPubMed
Lombard, DB, Alt, FW, Cheng, HL, Bunkenborg, J, Streeper, RS, Mostoslavsky, R, Kim, J, Yancopoulos, G, Valenzuela, D, Murphy, A, Yang, Y, Chen, Y, Hirschey, MD, Bronson, RT, Haigis, M, Guarente, LP, Farese, RV Jr, Weissman, S, Verdin, E, and Schwer, B (2007) Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Molecular and Cellular Biology 27, 8807–8814. doi: 10.1128/mcb.01636-07CrossRefGoogle ScholarPubMed
Lu, A and Wu, H (2015) Structural mechanisms of inflammasome assembly. Febs 282, 435–444. doi: 10.1111/febs.13133CrossRefGoogle ScholarPubMed
Lucantoni, F, Martínez-Cerezuela, A, Gruevska, A, Moragrega, Á B, Víctor, VM, Esplugues, JV, Blas-García, A, and Apostolova, N (2021) Understanding the implication of autophagy in the activation of hepatic stellate cells in liver fibrosis: are we there yet? Journal of Pathology 254, 216–228. doi: 10.1002/path.5678CrossRefGoogle ScholarPubMed
Mahla, R, Reddy, C, Prasad, D, and Kumar, H (2013) Sweeten PAMPs: role of sugar complexed PAMPs in innate immunity and vaccine biology. Frontiers in Immunology 4. doi: 10.3389/fimmu.2013.00248CrossRefGoogle ScholarPubMed
Mao, L, Zhang, L, Li, H, Chen, W, Wang, H, Wu, S, Guo, C, Lu, A, Yang, G, and An, L (2014) Pathogenic fungus Microsporum canis activates the NLRP3 inflammasome. Infection and Immunity 82, 882–892.CrossRefGoogle ScholarPubMed
Meng, N, Xia, M, Lu, YQ, Wang, M, Boini, KM, Li, PL, and Tang, WX (2016) Activation of NLRP3 inflammasomes in mouse hepatic stellate cells during Schistosoma J. infection. Oncotarget 7, 39316–39331. doi: 10.18632/oncotarget.10044CrossRefGoogle ScholarPubMed
Mohamed, AH, El-Din, ATS, Mohamed, AM, and Habib, MR (2011) Tissue responses exhibited by Biomphalaria alexandrina snails from different Egyptian localities following Schistosoma mansoni exposure. Experimental Parasitology 127, 789–794.CrossRefGoogle ScholarPubMed
Mukherjee, S, Mo, J, Paolella, LM, Perry, CE, Toth, J, Hugo, MM, Chu, Q, Tong, Q, Chellappa, K, and Baur, JA (2021) SIRT3 is required for liver regeneration but not for the beneficial effect of nicotinamide riboside. JCI Insight, 6, 147193.CrossRefGoogle Scholar
Nagy, LE (2015) The role of innate immunity in alcoholic liver disease. Alcohol Research 37, 237–250.Google ScholarPubMed
Ning, ZW, Luo, XY, Wang, GZ, Li, Y, Pan, MX, Yang, RQ, Ling, XG, Huang, S, Ma, XX, Jin, SY, Wang, D, and Li, X (2017) MicroRNA-21 mediates Angiotensin II-induced liver fibrosis by activating NLRP3 inflammasome/IL-1β axis via targeting Smad7 and Spry1. Antioxidants & Redox Signaling 27, 1–20. doi: 10.1089/ars.2016.6669CrossRefGoogle ScholarPubMed
Niu, X, Hu, T, Hong, Y, Li, X, and Shen, Y (2022) The role of praziquantel in the prevention and treatment of fibrosis associated with schistosomiasis: a review. Journal of Tropical Medicine 2022, 1413711. doi: 10.1155/2022/1413711CrossRefGoogle ScholarPubMed
Pellegrino, J, Oliveira, CA, Faria, J, and Cunha, AS (1962) New approach to the screening of drugs in experimental schistosomiasis mansoni in mice. American Journal of Tropical Medicine and Hygiene 11, 201–215.CrossRefGoogle Scholar
Percie du Sert, N, Hurst, V, Ahluwalia, A, Alam, S, Avey, MT, Baker, M, Browne, WJ, Clark, A, Cuthill, IC, Dirnagl, U, Emerson, M, Garner, P, Holgate, ST, Howells, DW, Karp, NA, Lazic, SE, Lidster, K, MacCallum, CJ, Macleod, M, Pearl, EJ, Petersen, OH, Rawle, F, Reynolds, P, Rooney, K, Sena, ES, Silberberg, SD, Steckler, T, and Würbel, H (2020) The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. British Journal of Pharmacology 177, 3617–3624. doi: 10.1111/bph.15193CrossRefGoogle ScholarPubMed
Pu, X, Storr, SJ, Zhang, Y, Rakha, EA, Green, AR, Ellis, IO, and Martin, SG (2017) Caspase-3 and caspase-8 expression in breast cancer: caspase-3 is associated with survival. Apoptosis 22, 357–368.CrossRefGoogle ScholarPubMed
Seki, E and Schwabe, RF (2015) Hepatic inflammation and fibrosis: functional links and key pathways. Hepatology 61, 1066–1079.CrossRefGoogle ScholarPubMed
Steers, GJ, Chen, GY, O’Leary, BR, Du, J, Van Beek, H, and Cullen, JJ (2022) Auranofin and pharmacologic ascorbate as radiomodulators in the treatment of pancreatic cancer. Antioxidants 11, 971.CrossRefGoogle ScholarPubMed
Tendler, M, Pinto, RM, Lima, AO, Gebara, G, and Katz, N (1986) Schistosoma mansoni: vaccination with adult worm antigens. International Journal for Parasitology 16, 347–352.CrossRefGoogle ScholarPubMed
Tsuchida, T and Friedman, SL (2017) Mechanisms of hepatic stellate cell activation. Nature Reviews Gastroenterology & Hepatology 14, 397–411.CrossRefGoogle ScholarPubMed
Vakrakou, AG, Boiu, S, Ziakas, PD, Xingi, E, Boleti, H, and Manoussakis, MN (2018) Systemic activation of NLRP3 inflammasome in patients with severe primary Sjögren’s syndrome fueled by inflammagenic DNA accumulations. Journal of Autoimmunity 91, 23–33.CrossRefGoogle ScholarPubMed
Van de Vijver KK, Colpaert CG, Jacobs, W, Kuypers, K, Hokke, CH, Deelder, AM, and Van Marck, EA (2006) The host’s genetic background determines the extent of angiogenesis induced by schistosome egg antigens. Acta Tropica 99, 243251. doi: 10.1016/j.actatropica.2006.08.011CrossRefGoogle ScholarPubMed
Wang, J, Ren, H, Yuan, X, Ma, H, Shi, X, and Ding, Y (2018) Interleukin-10 secreted by mesenchymal stem cells attenuates acute liver failure through inhibiting pyroptosis. Hepatology Research 48, e194–e202. doi: 10.1111/hepr.12969CrossRefGoogle ScholarPubMed
Wang, Y, Li, C, Gu, J, Chen, C, Duanmu, J, Miao, J, Yao, W, Tao, J, Tu, M, Xiong, B, Zhao, L, and Liu, Z (2020) Celastrol exerts anti-inflammatory effect in liver fibrosis via activation of AMPK-SIRT3 signalling. Journal of Cellular and Molecular Medicine 24, 941–953. doi: 10.1111/jcmm.14805CrossRefGoogle ScholarPubMed
WHO (2022) Schistosomiasis Secondary Schistosomiasis https://www.who.int/health-topic/schistosomiasis (accessed 24 January 2023).Google Scholar
Wree, A, McGeough, MD, Inzaugarat, ME, Eguchi, A, Schuster, S, Johnson, CD, Peña, CA, Geisler, LJ, Papouchado, BG, Hoffman, HM, and Feldstein, AE (2018) NLRP3 inflammasome driven liver injury and fibrosis: roles of IL-17 and TNF in mice. Hepatology 67, 736––49. doi: 10.1002/hep.29523CrossRefGoogle ScholarPubMed
Wree, A, McGeough, MD, Peña, CA, Schlattjan, M, Li, H, Inzaugarat, ME, Messer, K, Canbay, A, Hoffman, HM, and Feldstein, AE (2014) NLRP3 inflammasome activation is required for fibrosis development in NAFLD. Journal of Molecular Medicine 92, 1069–1082. doi: 10.1007/s00109-014-1170-1CrossRefGoogle ScholarPubMed
Xu, H, Hertzel, AV, Steen, KA, and Bernlohr, DA (2016) Loss of fatty acid binding protein 4/aP2 reduces macrophage inflammation through activation of SIRT3. Molecular Endocrinology 30, 325–334. doi: 10.1210/me.2015-1301CrossRefGoogle ScholarPubMed
Xu, X, Zhu, XP, Bai, JY, Xia, P, Li, Y, Lu, Y, Li, XY, and Gao, X (2019) Berberine alleviates nonalcoholic fatty liver induced by a high-fat diet in mice by activating SIRT3. Faseb Journal 33, 7289–7300. doi: 10.1096/fj.201802316RCrossRefGoogle ScholarPubMed
Zhang, J, Xiang, H, Liu, J, Chen, Y, He, RR, and Liu, B (2020a) Mitochondrial Sirtuin 3: new emerging biological function and therapeutic target. Theranostics 10, 8315–8342. doi: 10.7150/thno.45922CrossRefGoogle ScholarPubMed
Zhang, T, Fang, Z, Linghu, KG, Liu, J, Gan, L, and Lin, L (2020b) Small molecule-driven SIRT3-autophagy-mediated NLRP3 inflammasome inhibition ameliorates inflammatory crosstalk between macrophages and adipocytes. British Journal of Pharmacology 177, 4645–4665. doi: 10.1111/bph.15215CrossRefGoogle ScholarPubMed
Zhang, W-J, Fang, Z-M, and Liu, W-Q (2019) NLRP3 inflammasome activation from Kupffer cells is involved in liver fibrosis of Schistosoma japonicum-infected mice via NF-κB. Parasites & Vectors 12, 29. doi: 10.1186/s13071-018-3223-8CrossRefGoogle ScholarPubMed
Zhang, Y, Chen, L, Gao, W, Hou, X, Gu, Y, Gui, L, Huang, D, Liu, M, Ren, C, and Wang, S (2012) IL-17 neutralization significantly ameliorates hepatic granulomatous inflammation and liver damage in S chistosoma japonicum infected mice. European Journal of Immunology 42, 1523–1535.CrossRefGoogle Scholar